Veterinary Medicine Information website

Nobilis RT+IB multi+G+ND vakcina A.U.V.

Authorised
  • Infectious bursal disease virus, strain D78, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RT+IB multi+G+ND vakcina A.U.V.
Active substance:
  • Infectious bursal disease virus, strain D78, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain D78, Inactivated
    14.50
    log2 virus neutralising unit(s)
    /
    1.00
    unit(s)/dose
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    1.00
    unit(s)/dose
  • Newcastle disease virus, strain Clone 30, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        4
        week
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        4
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: